Tuesday, October 18, 2016

Ellimans Universal Muscle Rub Lotion





1. Name Of The Medicinal Product



Ellimans Universal Muscle Rub Lotion


2. Qualitative And Quantitative Composition



Ellimans Universal Muscle Rub Lotion contains:



Turpentine oil BP 35.41%



Glacial acetic acid EP 3.562%



For excipients, see 6.1



3. Pharmaceutical Form



Cutaneous emulsion



A creamy, white liniment having an odour of turpentine and acetic acid



4. Clinical Particulars



4.1 Therapeutic Indications



Symptomatic relief of muscular pain and stiffness including backache, sciatica, lumbago, fibrositis, and rheumatic pain and the massage by athletes of arm or leg muscles.



4.2 Posology And Method Of Administration



Shake the bottle immediately before use.



Adults and children aged 12 years and over.



Rub lotion freely onto affected part until thoroughly absorbed.



For the first 24 hours, apply every three hours, then twice daily.



Athletes: Massage of arm and leg muscles before and after activity.



Not to be used on children under 12 years of age.



The elderly



The adult directions for use apply.



4.3 Contraindications



Hypersensitivity to any of the ingredients.



4.4 Special Warnings And Precautions For Use



Do not apply when skin is broken or inflammed



Keep away from the eyes and other sensitive areas.



Keep out of reach and sight of children.



If symptoms persist, consult your doctor.



For external use only.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



Use in pregnancy and lactation is not contra-indicated, however, as with all medicines, care should be exercised.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



There have been reports that application to the skin of liniments containing Turpentine Oil may cause vesicular eruption, urticaria and vomiting in susceptible persons.



4.9 Overdose



Excessive percutaneous absorption as a result of over-application may rarely lead to reversible toxic nephritis.



Products containing turpentine, if ingested, could cause burning pain in the mouth and throat, abdominal pain, nausea, vomiting and occasionally diarrhoea.



This may be followed by painful urination, respiratory distress and convulsions. In high overdose, death may follow due to respiratory failure.



Treatment on Ingestion



The stomach should be emptied by aspiration and lavage, after which treatment is symptomatic.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



MA02A X – Other topical products for joint and muscular pain



Turpentine oil is a rubefacient and counter-irritant.



Acetic acid is a counter irritant.



5.2 Pharmacokinetic Properties



Not applicable.



5.3 Preclinical Safety Data



No data of relevance which is additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Dried whole egg powder (melange)



Purified Water



6.2 Incompatibilities



None known.



6.3 Shelf Life



3 years



6.4 Special Precautions For Storage



None.



6.5 Nature And Contents Of Container



Clear, white flint glass oval section bottles, with a screw-on wadless plastic cap fitted with an internal gasket contained in printed boxboard cartons, containing 100 ml of product



6.6 Special Precautions For Disposal And Other Handling



Shake the bottle before each use.



7. Marketing Authorisation Holder



Actavis Group PTC ehf



Reykjavíkurvegi 76-78



220 Hafnarfjordur



Iceland.



8. Marketing Authorisation Number(S)



PL 30306/0075



9. Date Of First Authorisation/Renewal Of The Authorisation



15 January 2003



10. Date Of Revision Of The Text



4 February 2009



11 DOSIMETRY (IF APPLICABLE)



12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS (IF APPLICABLE)





No comments:

Post a Comment